China Health Industries Holdings, Inc. (CHHE) Gross Margin (2017 - 2023)
China Health Industries Holdings (CHHE) has disclosed Gross Margin for 12 consecutive years, with 8.9% as the latest value for Q2 2023.
- For the quarter ending Q2 2023, Gross Margin rose 59110.0% year-over-year to 8.9%, compared with a TTM value of 5.33% through Mar 2024, down 818.0%, and an annual FY2023 reading of 0.2%, up 55488.0% over the prior year.
- Gross Margin was 8.9% for Q2 2023 at China Health Industries Holdings, down from 10.89% in the prior quarter.
- Across five years, Gross Margin topped out at 79.94% in Q4 2019 and bottomed at 600.0% in Q1 2022.
- Average Gross Margin over 5 years is 97.48%, with a median of 56.27% recorded in 2020.
- The sharpest move saw Gross Margin plummeted -66246bps in 2022, then soared 61089bps in 2023.
- Year by year, Gross Margin stood at 79.94% in 2019, then dropped by -27bps to 58.11% in 2020, then plummeted by -874bps to 450.0% in 2021, then tumbled by -33bps to 600.0% in 2022, then skyrocketed by 99bps to 8.9% in 2023.
- Business Quant data shows Gross Margin for CHHE at 8.9% in Q2 2023, 10.89% in Q1 2023, and 600.0% in Q2 2022.